<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many anticarcinogenic drugs kill <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells by inducing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the effects of <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> (<z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi>) on <z:chebi fb="0" ids="30621">arsenic trioxide</z:chebi> (As(2)O(3))-induced cell killing </plain></SENT>
<SENT sid="2" pm="."><plain>Low concentrations of <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> (200 micromol/l) inhibited the ability of As(2)O(3) to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line Raji </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> altered the form of cell <z:hpo ids='HP_0011420'>death</z:hpo> from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> to pyknosis/<z:mp ids='MP_0001651'>necrosis</z:mp> and also lowered the degree of cell killing by As(2)O(3) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> was capable of preventing caspase-3 activation induced by As(2)O(3) in Raji cells </plain></SENT>
<SENT sid="5" pm="."><plain>Incubation of cells with a <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi>-3 kinase (PI-3K) inhibitor, <z:chebi fb="0" ids="52289">wortmannin</z:chebi> (100 nmol/l), blocked the effects of <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> on As(2)O(3)-induced caspase-3 activation </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, the PI-3K inhibitor partially blocked the effects of <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> on up-regulation of Bcl-2 and Bcl-X(L) protein expression, down-regulation of Bax protein expression, and phosphorylation of Bcl-2 and IkappaBalpha </plain></SENT>
<SENT sid="7" pm="."><plain>This investigation demonstrated for the first time that low concentrations of <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> provide protection against the in vivo of As(2)O(3)-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>PI-3K plays a crucial role in enhancing cell survival during <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi>, inhibiting As(2)O(3)-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="9" pm="."><plain>As(2)O(3)-induced <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> may be enhanced by certain <z:chebi fb="11" ids="22586">antioxidants</z:chebi> in the treatment protocol </plain></SENT>
</text></document>